When activated, cannabinoid receptors 1 and 2 tend to reduce pain and inflammation, while a third receptor, TRPV1, promotes the sensation of pain and contributes to inflammation.

New preclinical research shows that cannabinoid cell surface receptor CB1 plays a tumor-suppressing role in human colorectal cancer, scientists report in the Aug. 1 edition of the journal Cancer ...

Testing a cannabinoid drug in disease models. The study explored the impact of WIN55.212-2, a synthetic compound targeting cannabinoid receptors, in rodent models mimicking early stages of ...

Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking ...

Cannabinoids are naturally occurring compounds found in the Cannabis sativa plant. Of over 480 different compounds present in the plant, only around 66 are termed cannabinoids. Skip to content ...

After testing the effect of the drug WIN55.212-2, which interacts with cannabinoid receptors, on rodents in the early stages of the disease, the team found "that they behaved in the same way as ...

As a cannabinoid compound, CBD influences your ECS, the natural pathway of cannabinoid receptors in your body. Through this connection, ...

While more research is necessary, some sources note that cannabinoid receptors may interfere with molecular pathways in the development of thyroid cancer, and could be potential therapeutic ...

Research led by the University of the Basque Country (UPV/EHU) has identified a potential therapeutic pathway involving cannabinoid receptors to counter memory impairment in early stages of ...